Tvardi Therapeutics has failed its…
Tvardi Therapeutics has failed its first big test as a [...]
Gilead and Arcus’ anti-TIGIT…
Gilead and Arcus’ anti-TIGIT antibody domvanalimab has been tied to [...]
Novo Nordisk is ending all work in…
Novo Nordisk is ending all work in cell therapy, including [...]
Johnson & Johnson may be…
Johnson & Johnson may be looking to deepen its relationship [...]
Cabaletta Bio’s CAR-T cell…
Cabaletta Bio’s CAR-T cell therapy successfully eliminated the overreactive B [...]
In an Oct. 9 discussion about…
In an Oct. 9 discussion about innovation, resilience and the [...]
The stars have aligned for Bristol…
The stars have aligned for Bristol Myers Squibb and Orbital [...]
Shuttle Pharmaceuticals has…
Shuttle Pharmaceuticals has rocketed into the AI-driven drug discovery space [...]
It’s still early in the season,…
It’s still early in the season, but Evommune has become [...]
Regeneron has posted updated…
Regeneron has posted updated clinical data on DB-OTO, providing more [...]